Prognostic Utility of Indoxyl Sulfate for Patients with Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Prognostic Utility of Indoxyl Sulfate for Patients with Acute Coronary Syndrome

Published:2019-01-01 Issue:1 Volume:26 Page:64-71
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Watanabe Ippei¹,Tatebe Junko²,Fujii Takahiro¹,Noike Ryota¹,Saito Daiga¹,Koike Hideki¹,Yabe Takayuki¹,Okubo Ryo¹,Nakanishi Rine¹,Amano Hideo¹,Toda Mikihito¹,Ikeda Takanori¹,Morita Toshisuke²

Affiliation:

1. Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine

2. Department of Laboratory Medicine, Toho University Faculty of Medicine

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/26/1/26_44149/_pdf

Reference35 articles.

1. 1) Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kele pouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ and Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 2003; 108: 2154-2169

2. 2) Liu S, Wang BH, Kompa AR, Lekawanvijit S and Krum H: Antagonists of organic anion transporters 1 and 3 ameliorate adverse cardiac remodelling induced by uremic toxin indoxyl sulfate. Int J Cardiol, 2012; 158: 457-458

3. 3) Pletinck A, Glorieux G, Schepers E, Cohen G, Gondouin B, Van Landschoot M, Eloot S, Rops A, Van de Voorde J, De Vriese A, van der Vlag J, Brunet P, Van Biesen W and Vanholder R: Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall. J Am Soc Nephrol, 2013; 24: 1981-1994

4. 4) Tumur Z, Shimizu H, Enomoto A, Miyazaki H and Niwa T: Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation. Am J Nephrol, 2010; 31: 435-441

5. 5) Hung SC, Kuo KL, Wu CC and Tarng DC: Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease. J Am Heart Assoc, 2017; 6:

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma concentration of TMAO is an independent predictor of adverse outcomes in patients after acute myocardial infarction;Advances in Interventional Cardiology;2023

2. A Clinical Association between an Increasing Renal Resistive Index and the Atherosclerotic Burden in Patients with a Preserved Renal Function;Internal Medicine;2020-04-01

3. The Incidence and Associated Factors of Sudden Death in Patients on Hemodialysis: 10-Year Outcome of the Q-Cohort Study;Journal of Atherosclerosis and Thrombosis;2020-04-01

4. Role of S-Equol, Indoxyl Sulfate, and Trimethylamine N-Oxide on Vascular Function;American Journal of Hypertension;2020-03-30

5. The Difference in the Changes of Indoxyl Sulfate after Catheter Ablation among Atrial Fibrillation Patients with and without Kidney Dysfunction;Scientific Reports;2020-01-16